Hippocratic AI Secures $126M Series C, Valuation Hits $3.5B

Hippocratic AI, a healthcare-focused artificial intelligence company founded in 2023, has raised $126 million in a Series C funding round led by Avenir Growth, boosting its valuation to $3.5 billion and bringing its total funding to $404 million. The company specializes in developing large language models specifically for healthcare, focusing on non-diagnostic, patient-facing applications such as appointment scheduling, patient intake, chronic disease management, and post-discharge outreach. Hippocratic AI emphasizes safety through its Polaris Safety Constellation Architecture, which involves multiple models cross-checking outputs to ensure accuracy and prevent harm, alongside rigorous testing and human oversight. Since launching its first commercial product in June 2024, the company has completed over 115 million patient interactions across more than 50 health systems, payers, and pharmaceutical organizations in six countries without any reported safety issues. With the new investment, Hippocratic AI plans to scale global deployments, accelerate product innovation, and explore mergers and acquisitions to expand its impact on healthcare. Investors include major health systems such as Universal Health Services and Cincinnati Children’s Hospital Medical Center, as well as venture capital firms like Andreessen Horowitz, CapitalG, and Kleiner Perkins.